Healthcare · Diagnostics Research · NASDAQ
| Market cap | $17.59B |
|---|---|
| Trailing P/E | 36.9 |
| FCF yield | 3.7% |
| Revenue growth (YoY) | +20.0% |
| EPS growth (YoY) | +20.8% |
| FCF/share growth (YoY) | +29.2% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Medpace Holdings, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| David J. Taylor | House | Buy | $1,001 - $15,000 | May 28, 2026 |
| David J. Taylor | House | Buy | $1,001 - $15,000 | Mar 6, 2026 |
| Gilbert Cisneros | House | Sell | $15,001 - $50,000 | Feb 13, 2026 |
| David J. Taylor | House | Buy | $1,001 - $15,000 | Feb 2, 2026 |
| David J. Taylor | House | Sell | $1,001 - $15,000 | Feb 2, 2026 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Nov 18, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Sep 12, 2025 |
| David J. Taylor | House | Sell | $1,001 - $15,000 | Sep 2, 2025 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Aug 14, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | Feb 13, 2025 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Aug 15, 2024 |